Secondary Logo

Journal Logo

ASAIO CARDIAC ABSTRACT

HOME DISCHARGE WITH A THORATEC VAD USING THE TLC-II PORTABLE DRIVER

Slaughter, M S1; Tsui, S L2; El-Banayosy, A3; Kormos, R L4; Icenogle, T B5; Hill, J D6

Author Information
  • Free

Background- Home Discharge with independent ambulation and self-care is now possible for patients on ventricular assist devices (VAD's). Results of the multicenter home discharge trial with Thoratec TLC-II portable driver are reviewed. Methods- Patients with a Thoratec VAD were evaluated for home discharge with the new TLC-II pneumatic portable driver. Five outpatient excursions (3 monitored) were required prior to discharge. Patients were seen weekly and data downloaded while at home. Results- Between December 2000 and June 2003, 26 patients (18 men) were discharged home. The median age was 50 yrs (range 21–73) and BSA 1.99m2, (range 1.49–2.79). Eight patients had BVAD's and 1 8 an LVAD with a median duration of support of 150 days. Time at home ranged from 13–255 days (mean 94). There was a total of 2361 days (6.5 yrs) of home experience. The TLC-II was kept in the auto mode with an average flow of 2.661/min/m2. Five patients are ongoing and two withdrawn. Seventeen patients (89%) survived to VAD removal (transplant 8, weaned 9) and 2(11%) expired on VAD support. There were 13 malfunctions (7 dirver, 3 battery, 2 VAD pump, 1 mobility cart). Eighteen patients required readmission with only 2 from VAD system components. Discharged patients spent 83% of their time out of the hospital. Conclusion- The TLC-II portable driver is safe and allows patients on Thoratec VAD's to be discharged home.

Copyright © 2004 by the American Society for Artificial Internal Organs